{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T10:06:56Z","timestamp":1792750016676,"version":"4.5.0"},"reference-count":163,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Nowadays, chronic benign and malignant prostatic diseases are prevalent, costly, and impose a significant burden. Benign prostatic hyperplasia (BPH), a common condition in the aging population, often coexists with localized prostate cancer (PCa). These diseases likely share underlying molecular mechanisms, which remain poorly understood. The exploration of novel cell subpopulations and specific biomarkers for accurate diagnosis and treatment of prostatic diseases is ongoing and holds great clinical promise. Prostate cell proliferation and immune inflammation are key contributors to the progression of BPH and PCa, involving various prostate and immune cell subpopulations. This raises important questions about how specific cell types drive phenotypic heterogeneity. Advanced single-cell RNA sequencing (scRNA-seq), a cutting-edge technology, offers unparalleled insights at the single-cell level. Similar to a microscope that identifies cell types within tissue samples, scRNA-seq elucidates cellular heterogeneity and diversity within single cell populations, positioning itself as a future-leading sequencing technology. Considering that BPH and PCa share androgen-dependent growth, chronic inflammation and specific microenvironmental changes, this review discusses recent discoveries of novel cell subpopulations and molecular signatures in BPH and PCa that can be dissected by scRNA-seq. It aims to help researchers better understand the molecular pathogenesis of these conditions while offering new therapeutic possibilities for clinical management of benign and malignant prostatic disorders.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1684895","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T06:38:33Z","timestamp":1767940713000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Advances in the identification of novel cell signatures in benign prostatic hyperplasia and prostate cancer using single-cell RNA sequencing"],"prefix":"10.3389","volume":"16","author":[{"given":"Yu","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingjie","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrestox.2c00328","article-title":"Toxicoproteomics of mono(2-ethylhexyl) phthalate and perfluorooctanesulfonic acid in models of prostatic diseases","volume":"36","author":"Thomas","year":"2023","journal-title":"Chem Res Toxicol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2419853","DOI":"10.1080\/13685538.2024.2419853","article-title":"Bidirectional influence between benign prostatic hyperplasia, prostate cancer, and prostatitis and mental disorders: two-sample and multivariate mendelian randomization analyses","volume":"27","author":"Chen","year":"2024","journal-title":"Aging Male"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.65384","article-title":"A systematic review and single-arm meta-analysis on the efficacy of high-intensity, focused ultrasound for benign prostatic hyperplasia treatment: A forgotten option","volume":"16","author":"Garcia-Becerra","year":"2024","journal-title":"Cureus"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1177\/03915603241274467","article-title":"Evaluation of efficacy of cholecalciferol and silymarin in improving lower urinary tract symptoms of benign prostatic hyperplasia: A double-blind, randomized, controlled trial","volume":"91","author":"Valipour","year":"2024","journal-title":"Urologia"},{"key":"B5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.prnil.2023.11.004","article-title":"Risks and side effects in the medical management of benign prostatic hyperplasia","volume":"12","author":"Halawani","year":"2024","journal-title":"Prostate Int"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s11934-024-01199-4","article-title":"Medical advancements in benign prostatic hyperplasia treatments","volume":"25","author":"Ganesan","year":"2024","journal-title":"Curr Urol Rep"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_433138","article-title":"Advancing prostate cancer care: treatment approaches to precision medicine, biomarker innovations, and equitable access","volume":"44","author":"Fenton","year":"2024","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-020-0332-z","article-title":"All change in the prostate cancer diagnostic pathway","volume":"17","author":"Lomas","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1101\/gad.315739.118","article-title":"Genetics and biology of prostate cancer","volume":"32","author":"Wang","year":"2018","journal-title":"Genes Dev"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyac035","article-title":"Narrative review of local prostate and metastasis-directed radiotherapy in the treatment of metastatic prostate cancer","volume":"52","author":"Terada","year":"2022","journal-title":"Jpn J Clin Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3892\/ol.2023.13749","article-title":"Prostate cancer bone metastases biology and clinical management (Review)","volume":"25","author":"Archer Goode","year":"2023","journal-title":"Oncol Lett"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.3390\/cancers15051518","article-title":"Bone metastases and health in prostate cancer: from pathophysiology to clinical implications","volume":"15","author":"Baldessari","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B13","article-title":"The survival of the prostate cancer patients with secondary colorectal cancer: a study based on a SEER database from southern China","volume":"27","author":"Lin","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s10151-023-02883-2","article-title":"Association of radiotherapy for prostate cancer and second primary colorectal cancer: a US population-based analysis","volume":"28","author":"Tang","year":"2023","journal-title":"Tech Coloproctol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"119986","DOI":"10.1016\/j.cca.2024.119986","article-title":"Benign prostatic hyperplasia genetic variants in Asians","volume":"565","author":"Mahbubi Sani","year":"2024","journal-title":"Clin Chim Acta"},{"key":"B16","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1080\/13685538.2022.2050360","article-title":"The association between histological prostatitis and benign prostatic hyperplasia: a single-center retrospective study","volume":"25","author":"Li","year":"2022","journal-title":"Aging Male"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.3390\/cancers15123110","article-title":"The molecular basis and clinical consequences of chronic inflammation in prostatic diseases: prostatitis, benign prostatic hyperplasia, and prostate cancer","volume":"15","author":"Oseni","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2391380","DOI":"10.1080\/13685538.2024.2391380","article-title":"Prostate-specific antigen, androgen, progesterone and oestrogen receptors in Benign prostatic hyperplasia: human tissues and animal model study","volume":"27","author":"Wang","year":"2024","journal-title":"Aging Male"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-022-04319-0","article-title":"Incidence and associated factors for incidental prostate cancer among patients who underwent surgery for benign prostatic hyperplasia: first report from Somalia","volume":"149","author":"Mohamed","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"B20","article-title":"The use of beta-sitosterol for the treatment of prostate cancer and benign prostatic hyperplasia","volume":"11","author":"Macoska","year":"2023","journal-title":"Am J Clin Exp Urol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2016.04.008","article-title":"Progesterone receptor in the prostate: A potential suppressor for benign prostatic hyperplasia and prostate cancer","volume":"166","author":"Chen","year":"2017","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1224913","article-title":"Unveiling novel insights in prostate cancer through single-cell RNA sequencing","volume":"13","author":"Yu","year":"2023","journal-title":"Front Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.21037\/tau-20-1383","article-title":"Rapidly evolving treatment paradigm and considerations for sequencing therapies in metastatic prostate cancer-a narrative review","volume":"10","author":"Sagaram","year":"2021","journal-title":"Transl Androl Urol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1355551","article-title":"Advances in sequencing and omics studies in prostate cancer: unveiling molecular pathogenesis and clinical applications","volume":"14","author":"Lu","year":"2024","journal-title":"Front Oncol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40779-024-00526-7","article-title":"The implications of single-cell RNA-seq analysis in prostate cancer: unraveling tumor heterogeneity, therapeutic implications and pathways towards personalized therapy","volume":"11","author":"Feng","year":"2024","journal-title":"Mil Med Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13045-021-01105-2","article-title":"Applications of single-cell sequencing in cancer research: progress and perspectives","volume":"14","author":"Lei","year":"2021","journal-title":"J Hematol Oncol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1186\/s12967-025-06996-0","article-title":"Droplet-based single-cell RNA sequencing: decoding cellular heterogeneity for breakthroughs in cancer, reproduction, and beyond","volume":"23","author":"Luo","year":"2025","journal-title":"J Transl Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e70512","DOI":"10.1002\/ctm2.70512","article-title":"Clinical application of single-cell RNA sequencing in disease and therapy","volume":"15","author":"Nadukkandy","year":"2025","journal-title":"Clin Transl Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s12032-025-03121-5","article-title":"Single-cell RNA sequencing in osteosarcoma: applications in diagnosis, prognosis, and treatment","volume":"42","author":"Asmar","year":"2025","journal-title":"Med Oncol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"39064","DOI":"10.31083\/FBL39064","article-title":"Advances in single-cell RNA sequencing: applications and mechanistic insights in haematopoietic Malignancies","volume":"30","author":"Guo","year":"2025","journal-title":"Front Biosci (Landmark Ed)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10555-025-10293-z","article-title":"Single-cell RNA-sequencing of circulating tumour cells: A practical guide to workflow and translational applications","volume":"44","author":"Tieng","year":"2025","journal-title":"Cancer Metastasis Rev"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-2025-606","article-title":"Single-cell analysis revealed a diagnostic model of hepatocellular carcinoma based on cancer stem cell-related gene","volume":"14","author":"Ding","year":"2025","journal-title":"Transl Cancer Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"102532","DOI":"10.1016\/j.tranon.2025.102532","article-title":"Integrated transcriptome and single-cell RNA sequencing analysis revealed the prognostic significance of GBP4 in pancreatic adenocarcinoma","volume":"61","author":"Chi","year":"2025","journal-title":"Transl Oncol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2174\/0118715303425071250925075308","article-title":"Single-cell profiling identifies JUNB\/SPI1-driven inflammatory programs and novel communication axes in myeloid cells of sepsis","author":"Liu","year":"2025","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.21037\/tau-2025-328","article-title":"Single-cell multi-omics and spatial transcriptomics reveal the transcriptional regulatory landscape of clear cell renal cell carcinoma","volume":"14","author":"Duan","year":"2025","journal-title":"Transl Androl Urol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"104820","DOI":"10.1016\/j.compbiomed.2021.104820","article-title":"UICPC: Centrality-based clustering for scRNA-seq data analysis without user input","volume":"137","author":"Chowdhury","year":"2021","journal-title":"Comput Biol Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4103\/aja.aja_100_18","article-title":"Toll-like receptor 10 (TLR10) exhibits suppressive effects on inflammation of prostate epithelial cells","volume":"21","author":"Fan","year":"2019","journal-title":"Asian J Androl"},{"key":"B38","doi-asserted-by":"publisher","first-page":"103495","DOI":"10.1016\/j.critrevonc.2021.103495","article-title":"Application of extracellular vesicles in the diagnosis and treatment of prostate cancer: Implications for clinical practice","volume":"167","author":"Oey","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13619-024-00206-w","article-title":"Application and new findings of scRNA-seq and ST-seq in prostate cancer","volume":"13","author":"Li","year":"2024","journal-title":"Cell Regener"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1134\/S0006297923020074","article-title":"Complex analysis of single-cell RNA sequencing data","volume":"88","author":"Khozyainova","year":"2023","journal-title":"Biochem (Mosc)"},{"key":"B41","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13046-021-01874-1","article-title":"Single-cell RNA sequencing in cancer research","volume":"40","author":"Zhang","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1016\/j.celrep.2018.11.086","article-title":"A cellular anatomy of the normal adult human prostate and prostatic urethra","volume":"25","author":"Henry","year":"2018","journal-title":"Cell Rep"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/pros.24661","article-title":"Transcriptomic analysis of benign prostatic hyperplasia identifies critical pathways in prostatic overgrowth and 5-alpha reductase inhibitor resistance","volume":"84","author":"Jin","year":"2024","journal-title":"Prostate"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/pros.24190","article-title":"The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms","volume":"81","author":"Jin","year":"2021","journal-title":"Prostate"},{"key":"B45","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12894-024-01585-7","article-title":"Autophagy in benign prostatic hyperplasia: insights and therapeutic potential","volume":"24","author":"Zhou","year":"2024","journal-title":"BMC Urol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.2147\/RRU.S477396","article-title":"The etiology and pathogenesis of benign prostatic hyperplasia: the roles of sex hormones and anatomy","volume":"16","author":"Xu","year":"2024","journal-title":"Res Rep Urol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.21037\/tau-24-209","article-title":"NOSTRIN is involved in benign prostatic hyperplasia via inhibition of proliferation, oxidative stress, and inflammation in prostate epithelial cells","volume":"13","author":"Li","year":"2024","journal-title":"Transl Androl Urol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030656","article-title":"The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia","volume":"349","author":"McConnell","year":"2003","journal-title":"N Engl J Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1097\/CU9.0000000000000233","article-title":"Hypoxia activates the hypoxia-inducible factor-1\u03b1\/vascular endothelial growth factor pathway in a prostatic stromal cell line: A mechanism for the pathogenesis of benign prostatic hyperplasia","volume":"18","author":"Zhang","year":"2024","journal-title":"Curr Urol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"114389","DOI":"10.1016\/j.biopha.2023.114389","article-title":"Hesperidin ameliorates benign prostatic hyperplasia by attenuating cell proliferation, inflammatory response, and epithelial-mesenchymal transition via the TGF-\u03b21\/Smad signaling pathway","volume":"160","author":"Kim","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B51","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1186\/s12967-024-05212-9","article-title":"Integrating spatial transcriptomics and single-cell RNA-sequencing reveals the alterations in epithelial cells during nodular formation in benign prostatic hyperplasia","volume":"22","author":"Fei","year":"2024","journal-title":"J Transl Med"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/path.6283","article-title":"Enhanced prostatic Esr1+ luminal epithelial cells in the absence of SRD5A2","volume":"263","author":"Sharkey","year":"2024","journal-title":"J Pathol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00018-024-05143-0","article-title":"Aberrant activated Notch1 promotes prostate enlargement driven by androgen signaling via disrupting mitochondrial function in mouse","volume":"81","author":"Kang","year":"2024","journal-title":"Cell Mol Life Sci"},{"key":"B54","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12967-024-05048-3","article-title":"Identification and functional activity of Nik related kinase (NRK) in benign hyperplastic prostate","volume":"22","author":"He","year":"2024","journal-title":"J Transl Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.1817","article-title":"Prostate Malignant tumor and benign prostatic hyperplasia microenvironments in black African men: Limited infiltration of CD8+ T lymphocytes, NK-cells, and high frequency of CD73+ stromal cells","author":"Mougola Bissiengou","year":"2023","journal-title":"Cancer Rep (Hoboken)"},{"key":"B56","doi-asserted-by":"publisher","first-page":"5969","DOI":"10.3390\/ijms22115969","article-title":"Resveratrol attenuates the proliferation of prostatic stromal cells in benign prostatic hyperplasia by regulating cell cycle progression, apoptosis, signaling pathways, BPH markers, and NF- \u03baB activity","volume":"22","author":"Jang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B57","doi-asserted-by":"publisher","first-page":"11634","DOI":"10.3390\/ijms241411634","article-title":"Mechanism of androgen-independent stromal proliferation in benign prostatic hyperplasia","volume":"24","author":"Hata","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1452887","article-title":"Bioassay-guided isolation of two antiproliferative metabolites from Pterocarpus indicus Willd. against TGF-\u03b2-induced prostate stromal cells (WPMY-1) proliferation via PI3K\/AKT signaling pathway","volume":"15","author":"Nwe","year":"2024","journal-title":"Front Pharmacol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s00345-024-04913-6","article-title":"Causal associations of immune cells with benign prostatic hyperplasia: insights from a Mendelian randomization study","volume":"42","author":"Li","year":"2024","journal-title":"World J Urol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.8051","article-title":"Progression of benign prostatic hyperplasia is associated with pro-inflammatory mediators and chronic activation of prostate-infiltrating lymphocytes","volume":"7","author":"Norstr\u00f6m","year":"2016","journal-title":"Oncotarget"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1494476","DOI":"10.3389\/fimmu.2024.1494476","article-title":"Infiltrating lipid-rich macrophage subpopulations identified as a regulator of increasing prostate size in human benign prostatic hyperplasia","volume":"15","author":"Lanman","year":"2025","journal-title":"Front Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"21029","DOI":"10.1038\/s41598-024-71137-4","article-title":"Characterization of prostate macrophage heterogeneity, foam cell markers, and CXCL17 upregulation in a mouse model of steroid hormone imbalance","volume":"14","author":"Silver","year":"2024","journal-title":"Sci Rep"},{"key":"B63","doi-asserted-by":"publisher","first-page":"101792","DOI":"10.1016\/j.jgo.2024.101792","article-title":"Localized prostate cancer in older patients: Radical prostatectomy or radiotherapy versus observation","volume":"15","author":"Petrelli","year":"2024","journal-title":"J Geriatr Oncol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-2659","article-title":"Computationally derived image signature of stromal morphology is prognostic of prostate cancer recurrence following prostatectomy in african american patients","volume":"26","author":"Bhargava","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2021202425","article-title":"Prognostic features of biochemical recurrence of prostate cancer following radical prostatectomy based on multiparametric MRI and immunohistochemistry analysis of MRI-guided biopsy specimens","volume":"299","author":"Harmon","year":"2021","journal-title":"Radiology"},{"key":"B66","doi-asserted-by":"publisher","first-page":"176982","DOI":"10.1016\/j.ejphar.2024.176982","article-title":"Advances in localized prostate cancer: A special focus on photothermal therapy","volume":"983","author":"Pinho","year":"2024","journal-title":"Eur J Pharmacol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.cll.2023.08.003","article-title":"Molecular pathology of prostate cancer","volume":"44","author":"Kulac","year":"2024","journal-title":"Clin Lab Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2020.04.017","article-title":"Oncological control following partial gland ablation for intermediate-risk prostate cancer","volume":"38","author":"Becher","year":"2020","journal-title":"Urol Oncol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2024.05.014","article-title":"Randomized trials of PSA screening","volume":"25","author":"Dave","year":"2024","journal-title":"Urol Oncol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"109036","DOI":"10.1016\/j.steroids.2022.109036","article-title":"Estrogen receptor expression is modulated in human and mouse prostate epithelial cells during cancer progression","volume":"184","author":"Gadkar","year":"2022","journal-title":"Steroids"},{"key":"B71","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/pros.23446","article-title":"Estrogen receptor signaling in prostate cancer: Implications for carcinogenesis and tumor progression","volume":"78","author":"Bonkhoff","year":"2018","journal-title":"Prostate"},{"key":"B72","doi-asserted-by":"crossref","first-page":"14917","DOI":"10.3390\/ijms232314917","article-title":"Cancer stemness\/epithelial-mesenchymal transition axis influences metastasis and castration resistance in prostate cancer: potential therapeutic target","volume":"23","author":"Castell\u00f3n","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B73","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3390\/bios14100503","article-title":"Electrical impedance spectroscopy as a tool to detect the epithelial to mesenchymal transition in prostate cancer cells","volume":"14","author":"Simpkins","year":"2024","journal-title":"Biosensors (Basel)"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-23-1954","article-title":"m6A modification promotes EMT and metastasis of castration-resistant prostate cancer by upregulating NFIB","volume":"84","author":"Shu","year":"2024","journal-title":"Cancer Res"},{"key":"B75","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.3390\/cancers16162776","article-title":"Liver X receptors enhance epithelial to mesenchymal transition in metastatic prostate cancer cells","volume":"16","author":"Bouchareb","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B76","doi-asserted-by":"publisher","first-page":"122180","DOI":"10.1016\/j.biomaterials.2023.122180","article-title":"Dynamic modulation of matrix adhesiveness induces epithelial-to-mesenchymal transition in prostate cancer cells in 3D","volume":"299","author":"Pol","year":"2023","journal-title":"Biomaterials"},{"key":"B77","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41420-023-01586-9","article-title":"Single-cell trajectory analysis reveals a CD9 positive state to contribute to exit from stem cell-like and embryonic diapause states and transit to drug-resistant states","volume":"9","author":"Li","year":"2023","journal-title":"Cell Death Discov"},{"key":"B78","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1819303116","article-title":"COX-2 mediates tumor-stromal prolactin signaling to initiate tumorigenesis","volume":"116","author":"Zheng","year":"2019","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B79","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41698-024-00667-x","article-title":"Unveiling novel double-negative prostate cancer subtypes through single-cell RNA sequencing analysis","volume":"8","author":"Cheng","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202105530","article-title":"Single-cell RNA-seq reveals a developmental hierarchy super-imposed over subclonal evolution in the cellular ecosystem of prostate cancer","volume":"9","author":"Ge","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1191311","article-title":"Lineage plasticity and treatment resistance in prostate cancer: the intersection of genetics, epigenetics, and evolution","volume":"14","author":"Imamura","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B82","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/bs.ircmb.2023.06.002","article-title":"Genetic and epigenetic features of neuroendocrine prostate cancer and their emerging applications","volume":"383","author":"Zhang","year":"2024","journal-title":"Int Rev Cell Mol Biol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"105398","DOI":"10.1016\/j.ebiom.2024.105398","article-title":"Integrated single-cell transcriptomic analyses identify a novel lineage plasticity-related cancer cell type involved in prostate cancer progression","volume":"109","author":"Zhao","year":"2024","journal-title":"EBioMedicine"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1186\/s12885-024-12926-y","article-title":"Single-cell sequencing analysis revealed that NEAT1 was a potential biomarker and therapeutic target of prostate cancer","volume":"24","author":"Li","year":"2024","journal-title":"BMC Cancer"},{"key":"B85","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.3390\/cancers16213685","article-title":"Deciphering the tumor microenvironment in prostate cancer: A focus on the stromal component","volume":"16","author":"Pakula","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B86","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s12672-024-01399-x","article-title":"Exploring the interaction between immune cells in the prostate cancer microenvironment combining weighted correlation gene network analysis and single-cell sequencing: An integrated bioinformatics analysis","volume":"15","author":"Hashemi Karoii","year":"2024","journal-title":"Discov Oncol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s00432-024-05983-0","article-title":"Unraveling molecular characteristics and tumor microenvironment dynamics of neuroendocrine prostate cancer","volume":"150","author":"Heimd\u00f6rfer","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.canlet.2021.10.027","article-title":"The evolving role of immune cells in prostate cancer","volume":"525","author":"Wang","year":"2022","journal-title":"Cancer Lett"},{"key":"B89","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12943-024-02137-1","article-title":"Prostate cancer microenvironment: multidimensional regulation of immune cells, vascular system, stromal cells, and microbiota","volume":"23","author":"Chen","year":"2024","journal-title":"Mol Cancer"},{"key":"B90","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3390\/life13020333","article-title":"Impact of immune cells in the tumor microenvironment of prostate cancer metastasis","volume":"13","author":"Messex","year":"2023","journal-title":"Life (Basel)"},{"key":"B91","doi-asserted-by":"publisher","first-page":"6036","DOI":"10.1038\/s41467-022-33780-1","article-title":"Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease","volume":"13","author":"Wong","year":"2022","journal-title":"Nat Commun"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1002\/pros.23742","article-title":"M2 macrophages and regulatory T cells in lethal prostate cancer","volume":"79","author":"Erlandsson","year":"2019","journal-title":"Prostate"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2020.00130","article-title":"Dynamics of cellular plasticity in prostate cancer progression","volume":"7","author":"Tiwari","year":"2020","journal-title":"Front Mol Biosci"},{"key":"B94","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.3390\/cancers15174357","article-title":"Lineage plasticity and stemness phenotypes in prostate cancer: harnessing the power of integrated \u201cOmics\u201d Approaches to explore measurable metrics","volume":"15","author":"Logotheti","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.3390\/ijms21051760","article-title":"Resveratrol suppresses prostate cancer epithelial cell scatter\/invasion by targeting inhibition of hepatocyte growth factor (HGF) secretion by prostate stromal cells and upregulation of E-cadherin by prostate cancer epithelial cells","volume":"21","author":"Hsieh","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B96","doi-asserted-by":"publisher","first-page":"101350","DOI":"10.1016\/j.tranon.2022.101350","article-title":"Non-enzymatic glycoxidation linked with nutrition enhances the tumorigenic capacity of prostate cancer epithelia through AGE mediated activation of RAGE in cancer associated fibroblasts","volume":"17","author":"Krisanits","year":"2022","journal-title":"Transl Oncol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1002\/pros.24723","article-title":"Cutibacterium acnes invades prostate epithelial cells to induce BRCAness as a possible pathogen of prostate cancer","volume":"84","author":"Ashida","year":"2024","journal-title":"Prostate"},{"key":"B98","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41467-021-27322-4","article-title":"Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states","volume":"13","author":"Song","year":"2022","journal-title":"Nat Commun"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.1073232","article-title":"Single-cell RNA sequencing reveals intratumoral heterogeneity and potential mechanisms of Malignant progression in prostate cancer with perineural invasion","volume":"13","author":"Zhang","year":"2023","journal-title":"Front Genet"},{"key":"B100","doi-asserted-by":"publisher","first-page":"e79076","DOI":"10.7554\/eLife.79076.sa2","article-title":"Defining cellular population dynamics at single-cell resolution during prostate cancer progression","volume":"11","author":"Germanos","year":"2022","journal-title":"Elife"},{"key":"B101","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12943-020-01264-9","article-title":"Identification of a distinct luminal subgroup diagnosing and stratifying early stage prostate cancer by tissue-based single-cell RNA sequencing","volume":"19","author":"Ma","year":"2020","journal-title":"Mol Cancer"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.4103\/0377-4929.85078","article-title":"Hepsin immunohistochemical expression in prostate cancer in relation to Gleason\u2019s grade and serum prostate specific antigen","volume":"54","author":"Goel","year":"2011","journal-title":"Indian J Pathol Microbiol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"9949","DOI":"10.1038\/s41467-024-54364-1","article-title":"Single cell and spatial transcriptomics highlight the interaction of club-like cells with immunosuppressive myeloid cells in prostate cancer","volume":"15","author":"Kiviaho","year":"2024","journal-title":"Nat Commun"},{"key":"B104","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1186\/s12967-023-04633-2","article-title":"Integrated machine learning identifies epithelial cell marker genes for improving outcomes and immunotherapy in prostate cancer","volume":"21","author":"Zhu","year":"2023","journal-title":"J Transl Med"},{"key":"B105","doi-asserted-by":"crossref","DOI":"10.1038\/s41416-022-02085-x","article-title":"Stromal cells in prostate cancer pathobiology: friends or foes","volume":"128","author":"Pederzoli","year":"2023","journal-title":"Br J Cancer"},{"key":"B106","article-title":"Role of prostate and bone stromal cells on prostate cancer progression","volume":"10","author":"Karkampouna","year":"2022","journal-title":"Am J Clin Exp Urol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-12-0085","article-title":"The reactive stroma microenvironment and prostate cancer progression","volume":"19","author":"Barron","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-13-1184","article-title":"Genes upregulated in prostate cancer reactive stroma promote prostate cancer progression","volume":"20","author":"Dakhova","year":"2014","journal-title":"vivo. Clin Cancer Res"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1002\/pros.24824","article-title":"Reactive stroma and acinar morphology in prostate cancer: implications for progression and prognostic assessment","volume":"85","author":"J\u00fanior","year":"2025","journal-title":"Prostate"},{"key":"B110","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.3390\/cancers16183215","article-title":"Evidence of the link between stroma remodeling and prostate cancer prognosis","volume":"16","author":"Vecchiotti","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.08.015","article-title":"Cyclooxygenase-dependent tumor growth through evasion of immunity","volume":"162","author":"Zelenay","year":"2015","journal-title":"Cell Mol Life Sci"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1412337","article-title":"Cancer-associated fibroblasts and prostate cancer stem cells: crosstalk mechanisms and implications for disease progression","volume":"12","author":"Chen","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-023-00827-x","article-title":"Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer","volume":"21","author":"Mori","year":"2024","journal-title":"Nat Rev Urol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1615\/CritRevOncog.2022043478","article-title":"Novel therapeutic targets and biomarkers associated with prostate cancer-associated fibroblasts (CAFs)","volume":"27","author":"Clark","year":"2022","journal-title":"Crit Rev Oncog"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1002\/path.5751","article-title":"Single-cell analysis of mouse and human prostate reveals novel fibroblasts with specialized distribution and microenvironment interactions","volume":"255","author":"Joseph","year":"2021","journal-title":"J Pathol"},{"key":"B116","article-title":"Role of tumor-associated immune cells in prostate cancer: angel or devil","volume":"21","author":"Wu","year":"2019","journal-title":"Asian J Androl"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12517","article-title":"Chronic prostatitis\/chronic pelvic pain syndrome and prostate cancer: study of immune cells and cytokines","volume":"34","author":"Liu","year":"2020","journal-title":"Fundam Clin Pharmacol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5081","article-title":"Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsy","volume":"6","author":"Kawahara","year":"2015","journal-title":"Oncotarget"},{"key":"B119","doi-asserted-by":"publisher","first-page":"486798","DOI":"10.1155\/2014\/486798","article-title":"The role of M1 and M2 macrophages in prostate cancer in relation to extracapsular tumor extension and biochemical recurrence after radical prostatectomy","volume":"2014","author":"Lanciotti","year":"2014","journal-title":"BioMed Res Int"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-5164","article-title":"Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing","volume":"14","author":"Sfanos","year":"2008","journal-title":"Clin Cancer Res"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20042028","article-title":"Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers","volume":"201","author":"Bronte","year":"2005","journal-title":"J Exp Med"},{"key":"B122","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13046-024-03063-2","article-title":"Icaritin-curcumol activates CD8+ T cells through regulation of gut microbiota and the DNMT1\/IGFBP2 axis to suppress the development of prostate cancer","volume":"43","author":"Xu","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1008856","article-title":"Crosstalk among long non-coding RNA, tumor-associated macrophages and small extracellular vesicles in tumorigenesis and dissemination","volume":"12","author":"Zhang","year":"2022","journal-title":"Front Oncol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"175087","DOI":"10.1016\/j.ejphar.2022.175087","article-title":"Cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs); where do they stand in tumorigenesis and how they can change the face of cancer therapy","volume":"928","author":"Tajaldini M","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2015.3400","article-title":"Alternatively activated macrophages are associated with metastasis and poor prognosis in prostate adenocarcinoma","volume":"10","author":"Hu","year":"2015","journal-title":"Oncol Lett"},{"key":"B126","doi-asserted-by":"publisher","first-page":"117002","DOI":"10.1016\/j.biopha.2024.117002","article-title":"Macrophage dynamics in prostate cancer: Molecular to therapeutic insights","volume":"177","author":"Gu","year":"2024","journal-title":"BioMed Pharmacother"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cell.2018.05.060","article-title":"Single-cell map of diverse immune phenotypes in the breast tumor microenvironment","volume":"174","author":"Azizi","year":"2018","journal-title":"Cell"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.7150\/jca.101042","article-title":"Integrating bulk and single-cell RNA-seq to construct a macrophage-related prognostic model for prognostic stratification in triple-negative breast cancer","volume":"15","author":"Zhao","year":"2024","journal-title":"J Cancer Res Clin Oncol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.18632\/aging.205727","article-title":"Comprehensive analysis of macrophage-related genes in prostate cancer by integrated analysis of single-cell and bulk RNA sequencing","volume":"16","author":"Zhang","year":"2024","journal-title":"Aging (Albany NY)"},{"key":"B130","doi-asserted-by":"publisher","first-page":"112599","DOI":"10.1016\/j.intimp.2024.112599","article-title":"Dissecting prostate Cancer: Single-Cell insight into Macrophage Diversity, molecular Prognosticators, and the role of Peptidylprolyl Isomerase F","volume":"138","author":"Guan","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-20-0740","article-title":"The prognostic potential of human prostate cancer-associated macrophage subtypes as revealed by single-cell transcriptomics","volume":"19","author":"Siefert","year":"2021","journal-title":"Mol Cancer Res"},{"key":"B132","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s10142-023-01037-9","article-title":"Integrated analysis of single-cell and bulk RNA sequencing identifies a signature based on macrophage marker genes involved in prostate cancer prognosis and treatment responsiveness","volume":"23","author":"Li","year":"2023","journal-title":"Funct Integr Genomics"},{"key":"B133","doi-asserted-by":"publisher","first-page":"110132","DOI":"10.1016\/j.celrep.2021.110132","article-title":"Resolving the immune landscape of human prostate at a single-cell level in health and cancer","volume":"37","author":"Tuong","year":"2021","journal-title":"Cell Rep"},{"key":"B134","doi-asserted-by":"publisher","first-page":"106571","DOI":"10.1016\/j.jsbmb.2024.106571","article-title":"Left out in the cold: Moving beyond hormonal therapy for the treatment of immunologically cold prostate cancer with CAR T cell immunotherapies","volume":"243","author":"Porter","year":"2024","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1399802","article-title":"Bi-specific T-cell engagers (BiTEs) in prostate cancer and strategies to enhance development: hope for a BiTE-r future","volume":"15","author":"Lampe","year":"2024","journal-title":"Front Pharmacol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"2356820","DOI":"10.1080\/15384047.2024.2356820","article-title":"T-Cell redirecting bispecific antibodies: a review of a novel class of immuno-oncology for advanced prostate cancer","volume":"25","author":"Palecki","year":"2024","journal-title":"Cancer Biol Ther"},{"key":"B137","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41556-020-00613-6","article-title":"Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression","volume":"23","author":"Chen","year":"2021","journal-title":"Nat Cell Biol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-0299","article-title":"Single-cell analysis reveals EP4 as a target for restoring T-cell infiltration and sensitizing prostate cancer to immunotherapy","volume":"28","author":"Peng","year":"2022","journal-title":"Clin Cancer Res"},{"key":"B139","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/medicines8060030","article-title":"The etiology and pathophysiology genesis of benign prostatic hyperplasia and prostate cancer: A new perspective","volume":"8","author":"Phua","year":"2021","journal-title":"Medicines (Basel)"},{"key":"B140","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3390\/ijms23020897","article-title":"Heat shock proteins in benign prostatic hyperplasia and prostate cancer","volume":"23","author":"Ratajczak","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B141","first-page":"qgae163","article-title":"Causal relationship between benign prostatic hyperplasia and prostate cancer: a bidirectional Mendelian randomization analysis","volume":"15","author":"Zhang","year":"2024","journal-title":"Postgrad Med J"},{"key":"B142","doi-asserted-by":"publisher","first-page":"3659","DOI":"10.3390\/cancers16213659","article-title":"G-protein-coupled receptor-associated sorting protein 1 overexpression is involved in the progression of benign prostatic hyperplasia, early-stage prostatic Malignant diseases, and prostate cancer","volume":"16","author":"Torres-Luna","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B143","doi-asserted-by":"publisher","first-page":"101079","DOI":"10.1016\/j.neo.2024.101079","article-title":"Epigenetic DNA modifications and vitamin C in prostate cancer and benign prostatic hyperplasia: Exploring similarities, disparities, and pathogenic implications","volume":"58","author":"Guz","year":"2024","journal-title":"Neoplasia"},{"key":"B144","doi-asserted-by":"publisher","first-page":"256","DOI":"10.31083\/j.fbl2907256","article-title":"Associations of CYLD, JAK2 and TLR4 genotypes with PSA levels and immunophenotype in benign prostatic hyperplasia and prostate cancer","volume":"29","author":"Duy","year":"2024","journal-title":"Front Biosci (Landmark Ed)"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/49.3.347","article-title":"Regional morphology and pathology of the prostate","volume":"49","author":"McNeal","year":"1968","journal-title":"Am J Clin Pathol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-024-04012-w","article-title":"Apparent differences in prostate zones: susceptibility to prostate cancer, benign prostatic hyperplasia and prostatitis","volume":"56","author":"Yu","year":"2024","journal-title":"Int Urol Nephrol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.17926","article-title":"Increased transcriptional and metabolic capacity for lipid metabolism in the peripheral zone of the prostate may underpin its increased susceptibility to cancer","volume":"8","author":"Al Kadhi","year":"2017","journal-title":"Oncotarget"},{"key":"B148","doi-asserted-by":"publisher","first-page":"4900","DOI":"10.3390\/molecules28134900","article-title":"Combination of lycopene and curcumin synergistically alleviates testosterone-propionate-induced benign prostatic hyperplasia in sprague dawley rats via modulating inflammation and proliferation","volume":"28","author":"Wang","year":"2023","journal-title":"Molecules"},{"key":"B149","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrurol.2012.192","article-title":"The link between benign prostatic hyperplasia and prostate cancer","volume":"10","author":"\u00d8rsted","year":"2013","journal-title":"Nat Rev Urol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.31557\/APJCP.2020.21.2.423","article-title":"Progesterone receptor expression in the benign prostatic hyperplasia and prostate cancer tissues, relation with transcription, growth factors, hormone reception and components of the AKT\/mTOR signaling pathway","volume":"21","author":"Spirina","year":"2020","journal-title":"Asian Pac J Cancer Prev"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.4155\/cli.14.77","article-title":"Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer","volume":"4","author":"Izumi","year":"2014","journal-title":"Clin Investig (Lond)"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0200613","article-title":"Androgen receptor isoforms expression in benign prostatic hyperplasia and primary prostate cancer","volume":"13","author":"Hillebrand","year":"2018","journal-title":"PLoS One"},{"key":"B153","article-title":"Expression of estrogen receptor-B (ER-B) in bengin and Malignant prostatic epithelial cells and its correlation with the clinico-pathological features","volume":"19","author":"Gabal","year":"2007","journal-title":"J Egypt Natl Canc Inst"},{"key":"B154","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41419-022-04979-3","article-title":"Estrogen and G protein-coupled estrogen receptor accelerate the progression of benign prostatic hyperplasia by inducing prostatic fibrosis","volume":"13","author":"Yang","year":"2022","journal-title":"Cell Death Dis"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0226057","article-title":"Estrogen receptor \u03b2 exerts tumor suppressive effects in prostate cancer through repression of androgen receptor activity","volume":"15","author":"Chaurasiya","year":"2020","journal-title":"PLoS One"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.730638","article-title":"Metabolomics profiling discriminates prostate cancer from benign prostatic hyperplasia within the prostate-specific antigen gray zone","volume":"11","author":"Xu","year":"2021","journal-title":"Front Oncol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1590\/S1677-55382011000500008","article-title":"Inflammation and endothelial activation in benign prostatic hyperplasia and prostate cancer","volume":"37","author":"Pace","year":"2011","journal-title":"Int Braz J Urol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.4103\/aja2021116","article-title":"A correlative study of iron metabolism based on q-Dixon MRI in benign prostatic hyperplasia and prostate cancer","volume":"24","author":"Tian","year":"2022","journal-title":"Asian J Androl"},{"key":"B159","doi-asserted-by":"publisher","first-page":"8895","DOI":"10.1038\/s41467-024-53039-1","article-title":"Targeting IRE1\u03b1 reprograms the tumor microenvironment and enhances anti-tumor immunity in prostate cancer","volume":"15","author":"Unal","year":"2024","journal-title":"Nat Commun"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.2174\/0109298673273303231208071403","article-title":"Activation of stimulator of interferon genes (STING): promising strategy to overcome immune resistance in prostate cancer","volume":"31","author":"Alnukhali","year":"2024","journal-title":"Curr Med Chem"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.3233\/CBM-230028","article-title":"CHRDL1, NEFH, TAGLN and SYNM as novel diagnostic biomarkers of benign prostatic hyperplasia and prostate cancer","volume":"38","author":"Su","year":"2023","journal-title":"Cancer biomark"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e22604","article-title":"Multi-omic diagnostics of prostate cancer in the presence of benign prostatic hyperplasia","volume":"9","author":"Spick","year":"2023","journal-title":"Heliyon"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S250829","article-title":"Biomarkers that differentiate benign prostatic hyperplasia from prostate cancer: A literature review","volume":"12","author":"McNally","year":"2020","journal-title":"Cancer Manag Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1684895\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T06:38:35Z","timestamp":1767940715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1684895\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":163,"alternative-id":["10.3389\/fimmu.2025.1684895"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1684895","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"article-number":"1684895"}}